Product Images Zavzpret
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 24 images provide visual information about the product associated with Zavzpret NDC 63539-135 by U.s. Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - zavegepant 01
Figure 1 - zavegepant 02
Figure 2 - zavegepant 03
Figure 3 - zavegepant 04
Figure 4 - zavegepant 05
Logo - zavegepant 06
Stfier is a product distributed by Pfizer Labs, which is a division of Pfizer Inc. based in New York, NY 10001.*
Logo - zavegepant 07
"Stfier" appears to be a not-available text as it does not provide any useful information. However, "Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10001" indicates that the product named "Stfier" is distributed by Pfizer Labs which is a division of Pfizer Inc. located in New York City.*
Figure A - zavegepant 08
Figure B - zavegepant 09
Figure C - zavegepant 10
Figure D - zavegepant 11
Figure E - zavegepant 12
Figure F - zavegepant 13
Figure G - zavegepant 14
Figure H - zavegepant 15
Figure I - zavegepant 16
Figure J - zavegepant 17
Figure K - zavegepant 18
The text suggests a breathing exercise to be done for 10-20 seconds, involving inhaling through the nose and exhaling through the mouth. Figure K may provide further context or visualization for the exercise.*
Figure L - zavegepant 19
Logo - zavegepant 20
Stfier is a product that is distributed by Pfizer Labs which is a division of Pfizer Inc. The physical location of Pfizer Inc. is in New York, NY 10001.*
PRINCIPAL DISPLAY PANEL – Nasal Spray Device Label Front Sample - zavzpret 07
PRINCIPAL DISPLAY PANEL – Nasal Spray Device Label Back Sample - zavzpret 08
The text refers to Pfizer Inc., a U.S. pharmaceuticals company. However, the number 141392 doesn't provide any context or information to generate a useful description.*
PRINCIPAL DISPLAY PANEL – Nasal Spray Blister Foil Label Sample - zavzpret 09
This is a professional sample of nasal spray labeled NDC 63539-135-01 containing 10mg of zavegepant per unit-dose. The product is for intranasal use only and should not be sprayed, primed, or press before use. Recommended dosage should be taken as per the prescribing information. The device should be stored at a temperature range of 20°C to 25°C, and it should be kept in the sealed blister package. The product is not intended for sale, and the label cautions against keeping it within children's reach. The distributor is P.U.S Pharmaceuticals, a division of Pfizer Inc. based in New York, NY.*
PRINCIPAL DISPLAY PANEL – Nasal Spray Carton Sample - zavzpret 10
ZAVZPRET (zavegepant) is a professional-use nasal spray containing 10 mg of zavegepant. Each unit-dose spray delivers 10 mg of zavegepant free base (equivalent to 10.6 mg of zavegepant hydrochloride) in an aqueous buffered solution containing dextrose, hydrochloric acid, sodium hydroxide, and succinic acid in water for injection. The recommended dosage and storage as well as warnings and instructions for use are provided on the package and the enclosed leaflet. For more information, visit zavzpret.com or call 1-800-436-1985. The product is not intended for sale. GTIN 0363539135026.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.